{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T01:59:07Z","timestamp":1771034347033,"version":"3.50.1"},"reference-count":17,"publisher":"Hindawi Limited","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":4142,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1368-5031.2004.00179.x","type":"journal-article","created":{"date-parts":[[2004,4,29]],"date-time":"2004-04-29T16:38:46Z","timestamp":1083256726000},"page":"340-345","source":"Crossref","is-referenced-by-count":26,"title":["Efficacy and tolerability of lumiracoxib in the treatment of primary dysmenorrhoea"],"prefix":"10.1155","volume":"58","author":[{"given":"M.","family":"Bitner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Kattenhorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Hatfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Kellstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2004,4,29]]},"reference":[{"key":"10.1111\/j.1368-5031.2004.00179.x-BIB1|cit1","first-page":"489","article-title":"Primary dysmenorrhea","volume":"60","author":"Coco","year":"1999","journal-title":"Am Fam Physician"},{"key":"10.1111\/j.1368-5031.2004.00179.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0029-7844(95)00360-6","article-title":"The prevalence of dysmenorrhea, dyspareunia, pelvic pain, and irritable bowel syndrome in primary care practices","volume":"87","author":"Jamieson","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1111\/j.1368-5031.2004.00179.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/0002-9378(82)90433-1","article-title":"An epidemiologic study of young women with dysmenorrhea","volume":"144","author":"Andersch","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/j.1368-5031.2004.00179.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1471-0528.1990.tb02545.x","article-title":"Factors influencing the prevalence and severity of dysmenorrhea in young women","volume":"97","author":"Sundell","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1111\/j.1368-5031.2004.00179.x-BIB5|cit5","first-page":"1443","article-title":"Prostaglandin levels in menstrual fluid of nondysmenorrheic and of dysmenorrheic subjects with and without oral contraceptive or ibuprofen therapy","volume":"8","author":"Chan","year":"1980","journal-title":"Adv Prostaglandin Thromboxane Res"},{"key":"10.1111\/j.1368-5031.2004.00179.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1471-0528.1998.tb10210.x","article-title":"Efficacy of minor analgesics in primary dysmenorrhea: a systematic review","volume":"105","author":"Zhang","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"issue":"Suppl.","key":"10.1111\/j.1368-5031.2004.00179.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S0885-3924(02)00628-0","article-title":"Strategies in pain management: new and potential indications for COX-2 specific inhibitors","volume":"25","author":"Ruoff","year":"2003","journal-title":"J Pain Symptom Manage"},{"issue":"Suppl. 3A","key":"10.1111\/j.1368-5031.2004.00179.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"20S","DOI":"10.1016\/S0002-9343(00)00682-3","article-title":"Epidemiological assessment of the safety of conventional nonsteroidal anti-inflammatory drugs","volume":"110","author":"Hernandez-Diaz","year":"2001","journal-title":"Am J Med"},{"key":"10.1111\/j.1368-5031.2004.00179.x-BIB9|cit9","first-page":"504","article-title":"Rofecoxib, a specific cyclooxygenase-2 inhibitor, in primary dysmenorrhea: a randomized controlled trial","volume":"94","author":"Morrison","year":"1999","journal-title":"Obstet Gynecol"},{"issue":"Suppl. 1","key":"10.1111\/j.1368-5031.2004.00179.x-BIB10|cit10","first-page":"141","article-title":"Pharmacokinetics and metabolism of lumiracoxib in healthy male subjects","volume":"34","author":"Mangold","year":"2002","journal-title":"Drug Metab Rev"},{"issue":"Suppl. 1","key":"10.1111\/j.1368-5031.2004.00179.x-BIB11|cit11","first-page":"128","article-title":"Pharmacokinetics and pharmacodynamics of COX189 in patients with knee or hip primary osteoarthritis","volume":"61","author":"Scott","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1368-5031.2004.00179.x-BIB12|cit12","unstructured":"Fricke J Zelenakas K Jayawardene S Kellstein D Lumiracoxib (Prexige \u00ae ) is an effective treatment for moderate-to-severe postoperative dental pain Congress Book of Abstracts: 4th Congress of the European Federation of IASP Chapters (EFIC), Pain in Europe IV"},{"key":"10.1111\/j.1368-5031.2004.00179.x-BIB13|cit13","unstructured":"Davis J Rhodes JR Wolf R et al. Lumiracoxib (Prexige \u00ae ) provides effective relief of postsurgical pain following total knee or hip arthroplasty Congress Book of Abstracts: 4th Congress of the European Federation of IASP Chapters (EFIC), Pain in Europe IV"},{"issue":"Suppl. 3","key":"10.1111\/j.1368-5031.2004.00179.x-BIB14|cit14","first-page":"A313","article-title":"Reduced cumulative incidence of gastroduodenal ulcers with two doses of a new coxib, COX189, compared with standard therapeutic doses of ibuprofen in osteoarthritis patients","volume":"51","author":"Hawkey","year":"2002","journal-title":"Gut"},{"issue":"Suppl. 1","key":"10.1111\/j.1368-5031.2004.00179.x-BIB15|cit15","first-page":"171","article-title":"Gastroduodenal safety and tolerability of lumiracoxib in patients with rheumatoid arthritis","volume":"62","author":"Kivitz","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1368-5031.2004.00179.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1046\/j.1365-2036.2003.01691.x","article-title":"Gastroduodenal tolerability of lumiracoxib vs placebo and naproxen: a pilot endoscopic study in healthy male subjects","volume":"18","author":"Rordorf","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1368-5031.2004.00179.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1542-3565(03)00318-5","article-title":"Pharmacology and gastrointestinal safety of lumiracoxib, a novel COX-2 selective inhibitor: A preliminary integrated study","volume":"2","author":"Atherton","year":"2004","journal-title":"Clinical Gastroenterology and Hepatology"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1368-5031.2004.00179.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1368-5031.2004.00179.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:03:52Z","timestamp":1643349832000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1368-5031.2004.00179.x"}},"subtitle":["Lumiracoxib in Primary Dysmenorrhoea"],"short-title":[],"issued":{"date-parts":[[2004,4,29]]},"references-count":17,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.1111\/j.1368-5031.2004.00179.x","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4,29]]}}}